A Phase II trial of dendritic cell (DC) immunotherapy for hepatocellular carcinoma

A Phase II trial of dendritic cell (DC) immunotherapy for hepatocellular carcinoma

Détails bibliographiques
Auteurs principaux:	Midgley, R, Kerr, D, Palmer, D, Mirza, N, Milner, A, Adams, D
Format:	Journal article
Publié:	2004

Documents similaires

A phase I/II dendritic cell (DC) immunotherapy trial for hepatocellular carcinoma (HC)
par: Midgley, R, et autres
Publié: (2002)

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.
par: Palmer, D, et autres
Publié: (2009)

Dendritic cell vaccination for hepatocellular carcinoma.
par: Midgley, R, et autres
Publié: (2003)

Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study
par: Jeong-Hoon Lee, et autres
Publié: (2017-07-01)

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
par: Raquel S Laureano, et autres
Publié: (2022-12-01)

Immunotherapy for colorectal cancer: a challenge to clinical trial design.
par: Midgley, R, et autres
Publié: (2000)

Immunotherapy for colorectal cancer.
par: Midgley, R, et autres
Publié: (2003)

Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy
par: Shao-Li Huang, et autres
Publié: (2021-07-01)

Thymostimulin in advanced hepatocellular carcinoma: A phase II trial
par: Behl Susanne, et autres
Publié: (2008-03-01)

Immunotherapy for colorectal cancer: potential application in an adjuvant setting.
par: Kerr, D, et autres
Publié: (2000)

Immunotherapy for colorectal cancer: Potential application in an adjuvant setting
par: Kerr, D, et autres
Publié: (2000)

Immunotherapy for hepatocellular carcinoma
par: Xiaoxia Wang, et autres
Publié: (2024-08-01)

Trial watch: Dendritic cell-based anticancer immunotherapy
par: Abhishek D. Garg, et autres
Publié: (2017-07-01)

Trial watch: dendritic cell vaccination for cancer immunotherapy
par: Jenny Sprooten, et autres
Publié: (2019-11-01)

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma
par: Feun LG, et autres
Publié: (2018-01-01)

Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation
par: Zecong Xiao, et autres
Publié: (2023-03-01)

T Cell–Associated Immunotherapy for Hepatocellular Carcinoma
par: Weijie Ma, et autres
Publié: (2017-02-01)

Activation of human dendritic cells for immunotherapy in ovarian carcinoma
par: Brencicova, E, et autres
Publié: (2012)

A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma
par: Dae-Won Lee, et autres
Publié: (2018-03-01)

Immunotherapies for advanced hepatocellular carcinoma
par: Li-Yang Sun, et autres
Publié: (2023-03-01)

Neoadjuvant Immunotherapy for Hepatocellular Carcinoma
par: Marron TU, et autres
Publié: (2022-06-01)

Editorial: Immunotherapy in Hepatocellular Carcinoma
par: Bin Li, et autres
Publié: (2021-06-01)

Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma
par: Manfredi GF, et autres
Publié: (2023-11-01)

Comparison of monocyte versus CD34+precursors for the generation of clinical grade dendritic cells for immunotherapy protocols in hepatocellular carcinoma
par: Daniels, H, et autres
Publié: (2005)

Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling
par: Robin K. Kelley, et autres
Publié: (2021-09-01)

Immune cell infiltration and immunotherapy in hepatocellular carcinoma
par: Yu Jiang, et autres
Publié: (2022-05-01)

A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma
par: Apostolos Sarivalasis, et autres
Publié: (2019-11-01)

Understanding Dendritic Cells and Their Role in Cutaneous Carcinoma and Cancer Immunotherapy
par: Valerie R. Yanofsky, et autres
Publié: (2013-01-01)

Post-operative adjuvant immunotherapy with cytokine-induced killer and dendritic cells for hepatocellular carcinoma: A systematic review and meta-analysis
par: Huijun Guo, et autres
Publié: (2023-06-01)

Immunotherapy for hepatocellular carcinomaKey points
par: Alexa Childs, et autres
Publié: (2024-10-01)

Complications of immunotherapy in advanced hepatocellular carcinoma
par: Young-Gi Song, et autres
Publié: (2024-03-01)

Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
par: Fuat Bicer, et autres
Publié: (2023-11-01)

Inflammatory microenvironment and immunotherapy in hepatocellular carcinoma
par: Liwei Liu, et autres
Publié: (2023-04-01)

Bibliometric study of immunotherapy for hepatocellular carcinoma
par: Zhiyi Li, et autres
Publié: (2023-08-01)

Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments
par: Wenya Li, et autres
Publié: (2024-09-01)

Demographics and Immunotherapy Efficacy for Advanced Hepatocellular carcinoma: A Systematic Review and Meta-Analysis of Phase III Clinical Trials
par: Yu-Yun Shao, et autres
Publié: (2024-11-01)

Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial
par: Xiaoyang Hong, et autres
Publié: (2025-02-01)

Hepatocellular carcinoma immunotherapy: The impact of epigenetic drugs and the gut microbiome
par: Farzam Vaziri, et autres
Publié: (2020-12-01)

Immunotherapy for hepatocellular carcinoma in liver transplant patients (Literature review)
par: I. A. Dzhanyan, et autres
Publié: (2023-09-01)

Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
par: Midgley, R, et autres
Publié: (2005)